India’s apex body on immunisation NTAGI has recommended administering the second dose of COVID-19 vaccine Covishield between eight and 16 weeks after the first dose, official sources said on Sunday Presently, the second dose of Covishield is given between 12-16 weeks after the first dose under the National COVID-19 Vaccination Strategy. The National Technical Advisory…Continue Reading
Notwithstanding having the ‘best of vaccines’, the USA is on the verge of giving a green signal to another vaccine soon to tame the ever-changing variants of SARS-CoV2, including Omicron; whereas the ‘Made in India’ vaccines like Covaxin and Covishield seem to have taken a better grip of mutating Covid-19 virus in India.As per Pfizer…Continue Reading
Two doses of the COVID-19 vaccination might not have been “completely effective” in offering total protection during the hypervirulent Delta variant wave, so, therefore, scientists now say that an additional third booster jab might mitigate the severity of B.1.1.529 Omicron variant, reducing the disease symptoms by 75%. Scientists in the UK found that the COVID-19…Continue Reading
In two to three weeks, it will be clear how effective Covishield vaccine is against COVID-19 variant Omicron, Adar Poonawalla, the chief of Serum Institute of India which manufactures the Indian version of the Oxford-AstraZeneca vaccine, told a news channel on Monday. In an interview to NDTV, Poonawala said that Omicron-specific booster shots are possible…Continue Reading
In India, no cases of the new variant have been detected yet, but the government says it is preparing to deal with it…Continue Reading